Intra-abdominal pressure (IAP) is the enduring state pressure covered inside the stomach cavity. The Intra-abdominal pressure measurement devices (IPMD) are utilized to quantify IAP in order to recognize people at the danger of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS). ACS and IAH can cause mortality and grimness because of cardiovascular output, modified respiratory mechanics and diminished venous return. This leads to the hindered hepatic bloodstream, respiratory breakdown, poor splanchnic perfusion, expanded intracranial weight, renal disappointment and end-organ brokenness and other potential issues. Hence, early acknowledgment and treatment of ACS and IAH utilizing IPMDs are crucial to enhancing mortality and morbidity among patients.
The worldwide market for intra-abdominal pressure measurement devices is projected to account for a market valuation of about US$ 44 Million throughout the year 2017 as well as is considered to be accounting for a value approximately US$ 174 Million by the end of the estimated period 2026, exhibiting a healthy double-digit CAGR of 16.5% during the nine-year assessment period.
The overall market on the basis of procedure type is broadly categorized into abdomen and muscle.
The worldwide market, based on the end user is categorized into clinics, ambulatory surgical centers, trauma centers and hospitals. Based on the product type the overall market is majorly segmented into equipment and disposables. On the basis of application, the worldwide market is divided into intra-compartment pressure and intra-abdominal hypertension.
The overall market on the basis of the region is analyzed across Japan, Asia Pacific excluding Japan, Eastern Europe, Western Europe, Latin America, North America and Middle East and Africa. North America is likely to continue dominating the worldwide market during the estimated period. The region was projected to account for about 56.4% of value share during 2016 and is expected to be accounting for a 59.0% of the overall market share over the estimated time frame. The North America market is anticipated to record a remarkable double digit CAGR of 17.0% in valuation terms during the calculated period. The Middle East and Africa market for intra-abdominal pressure measurement devices are likely to be the least attractive and lucrative regional market in the worldwide market for intra-abdominal pressure measurement devices in terms of revenue. The region accounted for only 2.1% of the overall market value share during 2016 and is estimated to be accounting for about 1.7% of the overall market value share through the end of the assessment year 2026.
The use and supply of intra-abdominal pressure measurement devices are determined in the developed regions such as Europe and North America. Nevertheless, regions such as Latin America, Asia Pacific along with GCC countries are likely to generate a noteworthy market opportunity for the prominent companies in the market throughout the assessment period owing to the aspects such as growing occurrences of chronic diseases along with increasing ICU admissions because of traumatic injuries in the rising economies.
Queries regarding these research findings can be addressed to Future Market Insights’ analysts at email@example.com